Literature DB >> 16926554

Relationship between 3-month National Institutes of Health Stroke Scale score and dependence in ischemic stroke patients.

Karen C Johnston1, Douglas P Wagner.   

Abstract

BACKGROUND: The National Institutes of Health Stroke Scale (NIHSS) provides a standardized measure of stroke severity and is frequently captured to assess 3-month outcome. Other outcome measures have been assessed for the relationship to dependence; a clinically relevant outcome. The relationship between NIHSS score and functional dependence is unknown. The purpose of this study was to assess the relationship between NIHSS score and accepted measures of dependence in surviving ischemic stroke patients.
METHODS: 3-month NIHSS scores were compared to residence and Glasgow Outcome Scale (GOS) scores at 3 months in the Randomized Trial of Tirilazad Mesylate in Patients with Acute Stroke (RANTTAS). For residence, patients who were in a nursing home, chronic hospital or substantially dependent on a caregiver were characterized as 'dependent'. For GOS, a score of 3 (severely disabled) or 4 (vegetative) was characterized as 'dependent'. The sensitivity, specificity and positive (PPV) and negative predictive values (NPV) for various NIHSS score cut points compared to dependence were calculated. Logistic regression analysis was used to assess the association between the NIHSS score and dependence.
RESULTS: In 385 subjects from the RANTTAS, an NIHSS score cut point of > or =15 resulted in 100% of subjects identified as being dependent by residence, sensitivity = 24%, specificity = 100%, PPV = 100% and NPV = 80%. Using GOS as the measure of dependence, the results were almost identical. NIHSS was strongly related to dependence with an area under the receiver operating characteristic curve (AUC) = 0.86 for residence and an AUC = 0.94 for GOS.
CONCLUSIONS: 3-month NIHSS score is strongly associated with dependence. An NIHSS score of > or =15 at 3 months may be a reasonable estimate of subjects who are highly likely to be dependent at 3 months. These data require validation in an independent data set.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926554      PMCID: PMC2749219          DOI: 10.1159/000095245

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

1.  Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial.

Authors:  R L Sacco; J T DeRosa; E C Haley; B Levin; P Ordronneau; S J Phillips; T Rundek; R G Snipes; J L Thompson
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

2.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

3.  Assessment of outcome after severe brain damage.

Authors:  B Jennett; M Bond
Journal:  Lancet       Date:  1975-03-01       Impact factor: 79.321

4.  If nothing goes wrong, is everything all right? Interpreting zero numerators.

Authors:  J A Hanley; A Lippman-Hand
Journal:  JAMA       Date:  1983-04-01       Impact factor: 56.272

5.  A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators.

Authors: 
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group.

Authors:  P Lyden; T Brott; B Tilley; K M Welch; E J Mascha; S Levine; E C Haley; J Grotta; J Marler
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

8.  Stroke rehabilitation: analysis of repeated Barthel index measures.

Authors:  C V Granger; L S Dewis; N C Peters; C C Sherwood; J E Barrett
Journal:  Arch Phys Med Rehabil       Date:  1979-01       Impact factor: 3.966

  8 in total
  5 in total

1.  Influence of Intracerebral Hemorrhage Location on Outcomes in Patients With Severe Intraventricular Hemorrhage.

Authors:  Vahid Eslami; Pouya Tahsili-Fahadan; Lucia Rivera-Lara; Dheeraj Gandhi; Hasan Ali; Adrian Parry-Jones; Lilli S Nelson; Richard E Thompson; Saman Nekoobakht-Tak; Rachel Dlugash; Nichol McBee; Isaam Awad; Daniel F Hanley; Wendy C Ziai
Journal:  Stroke       Date:  2019-06-10       Impact factor: 7.914

2.  Neurological Impairment Among Survivors of Intracerebral Hemorrhage: The FAST Trial.

Authors:  Michael C Christensen; Stephen Morris; Laura Vallejo-Torres; Catherine Vincent; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2011-10-06       Impact factor: 3.210

3.  The Role of Imaging in Clinical Stroke Scales That Predict Functional Outcome: A Systematic Review.

Authors:  Fatima Soliman; Ajay Gupta; Diana Delgado; Hooman Kamel; Ankur Pandya
Journal:  Neurohospitalist       Date:  2017-05-22

Review 4.  Assessment scales in stroke: clinimetric and clinical considerations.

Authors:  Jennifer K Harrison; Katherine S McArthur; Terence J Quinn
Journal:  Clin Interv Aging       Date:  2013-02-18       Impact factor: 4.458

5.  Correlation analysis of sleep quality and youth ischemic stroke.

Authors:  Shunqing Zhang; Cheng Chang; Juan Zhang; Bo Song; Hui Fang; YuMing Xu
Journal:  Behav Neurol       Date:  2014-08-05       Impact factor: 3.342

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.